Glucotrack (GCTK) EBIAT (2016 - 2020)
Glucotrack's EBIAT history spans 7 years, with the latest figure at -$879000.0 for Q4 2020.
- For the quarter ending Q4 2020, EBIAT fell 113.66% year-over-year to -$879000.0, compared with a TTM value of -$2.7 million through Dec 2020, down 176.68%, and an annual FY2025 reading of -$19.4 million, up 14.2% over the prior year.
- EBIAT for Q4 2020 was -$879000.0 at Glucotrack, down from -$509000.0 in the prior quarter.
- The five-year high for EBIAT was $18.0 million in Q4 2017, with the low at -$2.6 million in Q3 2017.
- Average EBIAT over 5 years is $135961.8, with a median of -$1.1 million recorded in 2016.
- Year-over-year, EBIAT soared 1680.11% in 2017 and then crashed 155.29% in 2019.
- Tracing GCTK's EBIAT over 5 years: stood at -$1.1 million in 2016, then soared by 1680.11% to $18.0 million in 2017, then crashed by 107.4% to -$1.3 million in 2018, then soared by 582.88% to $6.4 million in 2019, then crashed by 113.66% to -$879000.0 in 2020.
- Per Business Quant, the three most recent readings for GCTK's EBIAT are -$879000.0 (Q4 2020), -$509000.0 (Q3 2020), and -$574000.0 (Q2 2020).